Chapter One

Squid Raises $4m to Expand the Capabilities of the Cross-Chain Do-Anything Layer

Retrieved on: 
水曜日, 1月 31, 2024
Ethereum, Internet, Maelstrom, The Department, Non-fungible token, Polychain Capital, Investment, Squid, EVM, Specialization, NFT, Decentralized finance, XYZ, UX, Chapter One, LP, Cryptocurrency

ZUG, Switzerland , Jan. 31, 2024 /PRNewswire/ --  Squid, the cross-chain do-anything router, today announces $4m in strategic funding led by Polychain Capital with participation from Nomad Capital, North Island Ventures, Maelstrom, Chorus One, The Department of XYZ, Breed, Binary Builders, and Typhon Ventures, along with follow-on investments from Distributed Global, Fabric Ventures, Node Capital, and Chapter One. Squid has established itself as the fastest, most frictionless, and most secure way to swap tokens across blockchains, empowering users of thousands of assets on over 60 chains. This raise enables the team to continue its expansion in supporting chains in the EVM and Cosmos ecosystems and beyond. Additionally, the team will build deeper integrations with more decentralized applications (dApps), allowing users to easily interact with those applications in a wide variety of ways, including depositing into DeFi positions, purchasing NFT collectibles and in-game items, and more.

Key Points: 
  • This raise enables the team to continue its expansion in supporting chains in the EVM and Cosmos ecosystems and beyond.
  • "Our vision for Squid is to create the UX layer for interoperability among blockchains and the apps built on them," said Christina Rud, Co-Founder of the protocol.
  • With this raise, Squid will accelerate development to enable more complex bundling of transaction sequences and more efficient routing of assets.
  • Additionally, the team is building integrations with more interoperability networks and has its sights set on bringing Squid to more blockchain ecosystems beyond Ethereum and Cosmos.

Paradigm Spirits Co. Crowned 2024 Whisky of the Year by Esteemed Judges at the Canadian Whisky Awards

Retrieved on: 
木曜日, 1月 25, 2024
Chapter One, Gold Award, Liquor

LONDON, ON, Jan. 25, 2024 /CNW/ - Paradigm Spirits , a young and innovative distillery based in London, Ontario, is proud to announce that its 2022 Heritage Collection Whisky has been named 2024 Whisky of the Year by the distinguished panel of judges at the Canadian Whisky Awards .

Key Points: 
  • LONDON, ON, Jan. 25, 2024 /CNW/ - Paradigm Spirits , a young and innovative distillery based in London, Ontario, is proud to announce that its 2022 Heritage Collection Whisky has been named 2024 Whisky of the Year by the distinguished panel of judges at the Canadian Whisky Awards .
  • The enduring yearly awards ceremony took place on January 18, 2024, coinciding with the Victoria Whisky Festival.
  • The 2022 Heritage Collection, a 19-year-old, 100% corn whisky, showcases our dedication to pushing boundaries in Canadian whisky making."
  • To learn more about the 2024 Canadian Whisky Awards results, please visit Canadian Whisky Awards Results .

US Treasury market conditions and global market reactions to US monetary policy

Retrieved on: 
金曜日, 1月 19, 2024
Bank of England, BIS, Journal of Monetary Economics, Federal Reserve, Bank for International Settlements, COVID-19, Government, Bank, Response, Federal, United States Treasury security, BVAR, Repurchase agreement, Risk, Monetary economics, Interval (mathematics), Journal, International Monetary Fund, USD, Finance, Chapter One, Federal Reserve Bank, Absorption, ECB, Board of directors, Quarterly Review, Growth, Security (finance)

At the same time, leveraged funds have built up unusually large net short positions in the US Treasury futures market.

Key Points: 
  • At the same time, leveraged funds have built up unusually large net short positions in the US Treasury futures market.
  • This box provides empirical evidence that the impact of a US monetary policy shock on domestic and global bond markets may vary depending on conditions in the US Treasury market.

Global Diagnostics Distribution Deals Analysis Report and Directory 2016-2023 - ResearchAndMarkets.com

Retrieved on: 
水曜日, 12月 13, 2023
Biotechnology, Pharmaceutical, Health, Other Health, Confidentiality, Mecum Dealmakers, Chapter, Directory, Chapter Five, A-Z, Chapter Four, Orientation, Chapter Three, Chapter One, Medical device, Risk management, Commercial property, Cryptocurrency, Publishing, Lease, Property management

The "Distribution Deals in Diagnostics 2016 to 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Distribution Deals in Diagnostics 2016 to 2023" report has been added to ResearchAndMarkets.com's offering.
  • Fully revised and updated, the report provides details of distribution deals from 2016 to 2023.
  • Distribution Deals in Diagnostics provides a detailed understanding and analysis of how and why companies enter distribution deals.
  • The deal directory includes a comprehensive listing of all distribution deals announced since 2016.

Demesha Hill Appointed President of Janus Henderson Foundation

Retrieved on: 
火曜日, 12月 5, 2023
Finance, Foundation, Professional Services, Philanthropy, Asset Management, Janus, Titan, Janus Henderson, Champions Cup (snooker), NYSE, Organization, Investment, Chapter One, ASX, City, Organic, Diversity, Education, Cereal, Tutoring, Management

Demesha Hill, Head of Diversity and Community Relations at Janus Henderson Investors, has been appointed President of the Janus Henderson Foundation , Janus Henderson’s charitable giving arm.

Key Points: 
  • Demesha Hill, Head of Diversity and Community Relations at Janus Henderson Investors, has been appointed President of the Janus Henderson Foundation , Janus Henderson’s charitable giving arm.
  • In this relationship, the Janus Henderson Foundation provides funding and promotes volunteerism among Janus Henderson Investors’ employees, which has included employees tutoring and authoring financial literacy books for the library.
  • Demesha Hill, President of the Janus Henderson Foundation, said: “I’m honored to be entrusted with leading the Janus Henderson Foundation and look forward to continue working with our incredible charity partners around the world.
  • Janus Henderson Investors is the name under which investment products and services are provided by SEC registered investment advisers that are subsidiaries of Janus Henderson Group plc.

Immunology Collaboration and Licensing Agreements Analysis Report 2023 with Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 23, 2023
Biotechnology, Pharmaceutical, Health, Confidentiality, Chapter Six, Chapter, Intellectual property, Directory, Chapter Five, A-Z, Chapter Four, Hyperlink, Orientation, Chapter Three, Chapter One, Vaccine, Pharmaceutical industry, Cryptocurrency, Publishing, Risk management, Property management, Commercial property, Lease

Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the immunology deals entered into by the worlds leading biopharma companies.

Key Points: 
  • Immunology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the immunology deals entered into by the worlds leading biopharma companies.
  • Fully revised and updated, the report provides details of immunology deals from 2016 to 2023.
  • The report also includes numerous table and figures that illustrate the trends and activities in immunology deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of immunology deals signed and announced since 2016 where a contract document is available.

Global Hospital Care Collaboration and Licensing Agreements Analysis Report 2023 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 23, 2023
Health, Hospitals, Confidentiality, Chapter Six, Chapter, Intellectual property, Directory, Chapter Five, A-Z, Chapter Four, Hyperlink, Orientation, Chapter Three, Chapter One, Nursing, Cryptocurrency, Publishing, Risk management, Property management, Commercial property, Lease

Fully revised and updated, the report provides details of hospital care deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of hospital care deals from 2016 to 2023.
  • Hospital Care Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the hospital care deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in hospital care deal making since 2016.
  • Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in hospital care dealmaking.

Autoimmune Collaboration and Licensing Agreements Analysis Report 2023 with a Directory of Deals Signed Since 2016 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 23, 2023
Biotechnology, Pharmaceutical, Health, Chapter Six, Chapter, Directory, Chapter Five, A-Z, Chapter Four, Hyperlink, Orientation, Chapter Three, Chapter One, Collaboration, Cryptocurrency, Health insurance

Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of autoimmune deals from 2016 to 2023.
  • Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in autoimmune deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of autoimmune deals signed and announced since 2016 where a contract document is available.

Dermatology Collaboration and Licensing Deals Analysis Report and Directory 2016-2023 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 23, 2023
Biotechnology, Pharmaceutical, Health, Confidentiality, Chapter Six, Chapter, Intellectual property, Directory, Chapter Five, A-Z, Chapter Four, Hyperlink, Dermatology, Orientation, Chapter Three, Chapter One, Veterinary medicine, Commercial property, Cryptocurrency, Publishing, Risk management, Property management, Lease

The "Dermatology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Dermatology Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.
  • Fully revised and updated, the report provides details of dermatology deals from 2016 to 2023.
  • Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the worlds leading biopharma companies.
  • Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in dermatology dealmaking.

Ophthalmics Collaboration and Licensing Agreements Analysis Report 2023 with a Directory of Deals Signed by the World's Leading Biopharma Companies Since 2016 - ResearchAndMarkets.com

Retrieved on: 
木曜日, 11月 23, 2023
Health, Optical, Confidentiality, Chapter Six, Chapter, Intellectual property, Directory, Chapter Five, A-Z, Chapter Four, Hyperlink, Orientation, Chapter Three, Chapter One, Pharmaceutical industry, Cryptocurrency, Publishing, Risk management, Property management, Commercial property, Lease

Fully revised and updated, the report provides details of ophthalmics deals from 2016 to 2023.

Key Points: 
  • Fully revised and updated, the report provides details of ophthalmics deals from 2016 to 2023.
  • Ophthalmics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the ophthalmics deals entered into by the worlds leading biopharma companies.
  • The report also includes numerous table and figures that illustrate the trends and activities in ophthalmics deal making since 2016.
  • Chapter 5 provides a comprehensive and detailed review of ophthalmics deals signed and announced since 2016 where a contract document is available.